BRANDI PODBOY: Open Payments
NPI 1073101192 · TALLMADGE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 46 payments from 16 companies in 2025. Trend: 2023 $400 · 2024 $964 · 2025 $982
Food & beverage: $982
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $197 |
| ABBVIE INC. | 6 | $190 |
| AstraZeneca Pharmaceuticals LP | 7 | $116 |
| PFIZER INC. | 4 | $80 |
| GlaxoSmithKline, LLC. | 5 | $76 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $48 |
| Abbott Laboratories | 2 | $41 |
| Corcept Therapeutics | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
Products named: Ozempic, CREON, AIRSUPRA, TRELEGY ELLIPTA, ELIQUIS, VOQUEZNA, MOUNJARO, LINZESS.
Industry payments across OH — which companies pay providers there.
